Dr. Scott Gottlieb: Navigating Pharma Tariffs

April 15, 2025

Source: CNBC

Former FDA Commissioner Dr. Scott Gottlieb joins CNBC’s Squawk Box to discuss pharmaceutical import investigations, the impact of drug tariffs, and the shift in production of branded and generic medications to overseas facilities. He shares expert insights on U.S. drug policy, global supply chains, and the future of pharmaceutical manufacturing.

Dr. Scott Gottlieb is a leading authority on healthcare policy and pharmaceutical innovation, bringing unmatched insight from his time as FDA Commissioner. His expertise in drug safety, global supply chains, and regulatory strategy makes him an essential voice on the future of medicine and public health. Dr. Gottlieb’s speaking engagement are managed exclusively by WWSG. To host him for your event, contact us.

Relevant posts

Time to end secret data laboratories—starting with the CDC

The American people are waking up to the fact that too many public health leaders have not always been straight with them. Despite housing treasure…

Thought Leader: Marty Makary

Newt Gingrich | Election 2024 – State of the Race

Newt Gingrich discusses the upcoming election with two experienced pollsters, John McLaughlin and Doug Sosnik. They discuss key issues voters are considering, the six or…

Jay Clayton on taxing unrealized gains, price gouging ban proposals

Former SEC Chair Jay Clayton joins ‘Squawk Box’ to discuss the Trump vs. Harris economic agendas, taxing unrealized capital gains, federal price gouging ban, and…